Cancer Vaccine Plus Keytruda Improves Survival Without Relapse in Resected Melanoma
Findings from a phase 2 trial showed improvements in relapse-free survival with an mRNA vaccine plus Keytruda compared with Keytruda alone in patients with high-risk resected melanoma.
In Advanced Squamous Cell Carcinoma, Cosibelimab Led to Enduring Responses
The phase 1 study evaluated patient responses to cosibelimab in cases of locally advanced or metastatic cutaneous squamous cell carcinoma.
2 Commerce Drive Cranbury, NJ 08512